Skip to search formSkip to main contentSkip to account menu

Intravenous bisphosphonates

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Summary This is the first report on safety and efficacy of intravenous bisphosphonates (IV BP) for treatment of disuse… 
2019
2019
Abstract Objectives: Skeletal-related events (SREs), i.e. pathologic fractures, spinal cord compression, surgery and radiation to… 
2014
2014
OBJECTIVES To analyze whether oxidative stress (OS) changes are present in patients with bisphosphonate-related osteonecrosis of… 
2014
2014
AIM To determine the plasma and saliva levels of IL-6 in patients with bisphosphonate-related osteonecrosis of the jaws (BRONJ… 
2013
2013
PurposeCancer patients with bone metastases (BMets) are predisposed to skeletal complications. Bone-targeted therapies such as… 
Review
2010
Review
2010
e19619 Background: Metastatic bone disease is a common complication of several malignancies, including breast cancer, prostate… 
Highly Cited
2007
Highly Cited
2007
PURPOSE Denosumab, a fully human monoclonal antibody to receptor activator of nuclear factor-kappaB ligand, suppresses bone…